Vignola Mark J.
SEC insider (Form 3/4/5 filer). CIK 0001775429. Chief Financial Officer at Korsana Biosciences, Inc. (KRSA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2025. Located in WALTHAM, MA.
Companies Vignola Mark J. has filed insider reports for
- Korsana Biosciences, Inc. (KRSA): Officer, Chief Financial Officer
- Terns Pharmaceuticals, Inc. (TERN): Officer, Chief Financial Officer
Vignola Mark J.
CIK: 0001775429
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 6, 2025TERN
Terns Pharmaceuticals, Inc.
SaleDirect9.1K shares at avg. $5.80$52K - Jan 2, 2025TERN
Terns Pharmaceuticals, Inc.
SaleDirect8.1K shares at avg. $5.72$47K - Sep 10, 2024TERN
Terns Pharmaceuticals, Inc.
ExerciseDirect10K shares at avg. $5.36$54K - Sep 10, 2024TERN
Terns Pharmaceuticals, Inc.
SaleDirect10K shares at avg. $11.00$110K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 6, 2025 |  TERN Terns Pharmaceuticals, Inc. | Sale | 9,059 | $5.80 | $52,500 | Direct |
| Jan 2, 2025 | TERN Terns Pharmaceuticals, Inc. | Sale | 8,129 | $5.72 | $46,524 | Direct |
| Sep 10, 2024 | TERN Terns Pharmaceuticals, Inc. | Exercise | 10,000 | $5.36 | $53,600 | Direct |
| Sep 10, 2024 | TERN Terns Pharmaceuticals, Inc. | Sale | 10,000 | $11.00 | $110,000 | Direct |
1-4 of 4 transactions